Table 1.
Baseline Demographic and Clinical Characteristics Stratified by Median RAVI/LAVI.
| Characteristic | Below Median (n=56) | Above Median (n=56) | p-value |
|---|---|---|---|
| Age | 61.5 ± 13.7 | 58.78 ± 16.2 | 0.28 |
| Female Sex | 14 (24.6) | 19 (33.9) | 0.37 |
| Coronary Artery Disease | 41 (71.9) | 31 (55.7) | 0.10 |
| Type 2 Diabetes Mellitus | 34 (59.6) | 22 (39.3) | 0.04 |
| Chronic Kidney Disease | 24 (42.1) | 27 (48.2) | 0.64 |
| Chronic Obstructive Pulmonary Disease | 16 (28.1) | 10 (17.9) | 0.28 |
| Hypertension | 36 (63.2) | 32 (57.1) | 0.64 |
| Hyperlipidemia | 33 (57.9) | 36 (64.3) | 0.61 |
| Atrial Fibrillation | 24 (42.1) | 14 (25) | 0.08 |
| Ischemic Cardiomyopathy | 29 (52) | 27 (48) | 1.00 |
| Nonischemic Cardiomyopathy | 28 (51) | 27 (49) | 1.00 |
| Tobacco Abuse | 37 (64.9) | 33 (58.9) | 0.64 |
| Beta Blocker | 34 (59.6) | 38 (67.9) | 0.47 |
| ACEi* / ARB† | 26 (45.6) | 27 (48.2) | 0.93 |
| Aldosterone Antagonist | 15 (26.3) | 17 (30.4) | 0.78 |
| Diuretic | 38 (66.7) | 43 (76.8) | 0.32 |
| Home Inotrope | 4 (7.0) | 7 (12.5) | 0.50 |
| Mechanical Cardiac Support | 21 (38) | 26 (46) | 0.34 |
| Admission Lactic Acid | 2.9 ± 2.5 | 3.1 ± 2.0 | 0.81 |
| Admission Brain Natriuretic Peptide | 1664.8 ± 1163.5 | 2592.6 ± 2019.3 | 0.01 |
| Admission Creatinine | 1.8 ± 1.1 | 1.9 ± 1.1 | 0.47 |
a
Values are presented as mean ± standard deviation or n (%).
*
ACEi is angiotensin converting enzyme inhibitor
†
ARB is angiotensin receptor blocker.